NeuBase Therapeutics Inc Shares Approach 52-Week Low - Market Mover

The shares closed 0.9% above its 52-week low of $6.44, with trading volume higher than its 30 day average

Apr 07, 2021 by Kwhen Finance Editors

NeuBase Therapeutics Inc Shares Approach 52-Week Low - Market Mover
NeuBase Therapeutics Inc shares closed today at 0.9% above its 52 week low of $6.44, giving the company a market cap of $150M. The stock is currently down 7.0% year-to-date, down 20.1% over the past 12 months, and down 90.3% over the past five years. This week, the Dow Jones Industrial Average rose 1.9%, and the S&P 500 rose 2.7%.

Trading Activity

  • Trading volume this week was 80.4% higher than the 20-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.
  • The stock closed at 4.7% lower than its 5-day moving average, 15.7% lower than its 20-day moving average, and 24.6% lower than its 90-day moving average.

Market Comparative Performance

  • The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
  • The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
NeuBase Therapeutics Inc-3.0-7.0-20.1-49.51.1
Dow Jones Industrial Average0.811.045.3-0.749.9
S&P 500 Index0.710.450.3-0.852.9
Health Care1.03.928.1-2.529.5

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by -114.4%
  • The company's stock price performance over the past 12 months lags the peer average by -124.0%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
NeuBase Therapeutics IncNBSE0-7.0-20.1-49.51.1
Peer AvgN/A048.584.0-27.3188.2
Ocular Therapeutix IncOCUL0-20.2204.6-30.6254.4
OncoCyte CorpOCX0122.4117.8-20.1356.5
Oragenics Inc.OGEN092.013.5-58.4141.7

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: